skip to main content
DOE PAGES title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: A Rational Approach for Discovering and Validating Cancer Markers in Very Small Samples Using Mass Spectrometry and ELISA Microarrays

Abstract

Identifying useful markers of cancer can be problematic due to limited amounts of sample. Some samples such as nipple aspirate fluid (NAF) or early-stage tumors are inherently small. Other samples such as serum are collected in larger volumes but archives of these samples are very valuable and only small amounts of each sample may be available for a single study. Also, given the diverse nature of cancer and the inherent variability in individual protein levels, it seems likely that the best approach to screen for cancer will be to determine the profile of a battery of proteins. As a result, a major challenge in identifying protein markers of disease is the ability to screen many proteins using very small amounts of sample. In this review, we outline some technological advances in proteomics that greatly advance this capability. Specifically, we propose a strategy for identifying markers of breast cancer in NAF that utilizes mass spectrometry (MS) to simultaneously screen hundreds or thousands of proteins in each sample. The best potential markers identified by the MS analysis can then be extensively characterized using an ELISA microarray assay. Because the microarray analysis is quantitative and large numbers of samples can be efficiently analyzed,more » this approach offers the ability to rapidly assess a battery of selected proteins in a manner that is directly relevant to traditional clinical assays.« less

Authors:
 [1];  [1];  [2];  [1]
  1. Pacific Northwest National Laboratory, Richland, WA, USA
  2. University of California School of Nursing, Los Angeles, CA, USA
Publication Date:
Sponsoring Org.:
USDOE
OSTI Identifier:
1197934
Grant/Contract Number:  
ACO6-76RLO 1830
Resource Type:
Published Article
Journal Name:
Disease Markers
Additional Journal Information:
Journal Name: Disease Markers Journal Volume: 20 Journal Issue: 3; Journal ID: ISSN 0278-0240
Publisher:
Hindawi Publishing Corporation
Country of Publication:
Country unknown/Code not available
Language:
English

Citation Formats

Zangar, Richard C., Varnum, Susan M., Covington, Chandice Y., and Smith, Richard D. A Rational Approach for Discovering and Validating Cancer Markers in Very Small Samples Using Mass Spectrometry and ELISA Microarrays. Country unknown/Code not available: N. p., 2004. Web. doi:10.1155/2004/754640.
Zangar, Richard C., Varnum, Susan M., Covington, Chandice Y., & Smith, Richard D. A Rational Approach for Discovering and Validating Cancer Markers in Very Small Samples Using Mass Spectrometry and ELISA Microarrays. Country unknown/Code not available. doi:10.1155/2004/754640.
Zangar, Richard C., Varnum, Susan M., Covington, Chandice Y., and Smith, Richard D. Thu . "A Rational Approach for Discovering and Validating Cancer Markers in Very Small Samples Using Mass Spectrometry and ELISA Microarrays". Country unknown/Code not available. doi:10.1155/2004/754640.
@article{osti_1197934,
title = {A Rational Approach for Discovering and Validating Cancer Markers in Very Small Samples Using Mass Spectrometry and ELISA Microarrays},
author = {Zangar, Richard C. and Varnum, Susan M. and Covington, Chandice Y. and Smith, Richard D.},
abstractNote = {Identifying useful markers of cancer can be problematic due to limited amounts of sample. Some samples such as nipple aspirate fluid (NAF) or early-stage tumors are inherently small. Other samples such as serum are collected in larger volumes but archives of these samples are very valuable and only small amounts of each sample may be available for a single study. Also, given the diverse nature of cancer and the inherent variability in individual protein levels, it seems likely that the best approach to screen for cancer will be to determine the profile of a battery of proteins. As a result, a major challenge in identifying protein markers of disease is the ability to screen many proteins using very small amounts of sample. In this review, we outline some technological advances in proteomics that greatly advance this capability. Specifically, we propose a strategy for identifying markers of breast cancer in NAF that utilizes mass spectrometry (MS) to simultaneously screen hundreds or thousands of proteins in each sample. The best potential markers identified by the MS analysis can then be extensively characterized using an ELISA microarray assay. Because the microarray analysis is quantitative and large numbers of samples can be efficiently analyzed, this approach offers the ability to rapidly assess a battery of selected proteins in a manner that is directly relevant to traditional clinical assays.},
doi = {10.1155/2004/754640},
journal = {Disease Markers},
number = 3,
volume = 20,
place = {Country unknown/Code not available},
year = {2004},
month = {1}
}

Journal Article:
Free Publicly Available Full Text
Publisher's Version of Record
DOI: 10.1155/2004/754640

Citation Metrics:
Cited by: 16 works
Citation information provided by
Web of Science

Save / Share: